Search results
Verona's ensifentrine garners favorable reviews ahead of anticipated US launch for COPD
BioPharma-Reporter· 16 hours agoThe asset has gained positive opinions in the US market after data presented during the American...
5 Signs Your COPD Treatment Isn’t Working
Prevention via Yahoo News· 7 days ago5 Signs Your COPD Treatment Isn’t WorkingProfessionalStudioImages - Getty Images Although there isn’t currently a cure, you can find ways to live with...
A Guide for Living With COPD
Prevention· 5 days agoIn the past, chronic obstructive pulmonary disease (COPD)—a lung condition that limits airflow into your lungs and causes difficulty breathing—was...
FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD
Zacks via Yahoo Finance· 4 days agoPer the FDA, the data submitted by Sanofi (SNY)/Regeneron (REGN) for Dupixent in COPD indication...
How to Keep Your COPD Under Control, Even When Life Is Changing
Prevention via AOL· 6 days ago“Then, do what you can,” he says. Beyond that, Linnell stresses the importance of continuing with...
Find the Best COPD Care Team for You
Prevention via Yahoo News· 6 days ago“There are some people who are quite stable for many years, and some people have a more rapid progression,” says Craig Hersh, M.D., a...
5 Ways COPD Affects Your Mood—and How You Can Cope
Prevention via Yahoo News· 6 days agoAnd that can have a major impact on your mood. COPD patients who did pulmonary rehab for just three weeks had a significant drop in feelings of...
Small Business - Austin Daily Herald | Austin Daily Herald
Austin Daily Herald· 17 hours agoCOPD, a chronic respiratory condition, can drastically impact quality of life, making everyday tasks like walking or climbing stairs a struggle. Oftentimes, patients know ...
Dupilumab Improves Outcomes in COPD With Type 2 Inflammation
Medscape· 7 days agoNew trial confirmed safety and efficacy of a subcutaneous add-on therapy for uncontrolled COPD.
Verona prepares for anticipated US launch of ensifentrine for COPD in Q3 2024
Pharmaceutical Technology via Yahoo Finance· 6 days ago"Verona prepares for anticipated US launch of ensifentrine for COPD in Q3 2024" was originally...